Clinical Study of Efficacy and Safety of Baweidihuang-wan in patients with Overactive Bladder

Dongguk University0 个研究点目标入组 186 人开始时间: 待定最近更新: 2019年3月11日

适应症

试验速览

暂无简介。

•1) female aged more than 40
•2) symptoms of urinary urgency and frequency more than 3months.
•3) korea OABSS >3 at first visit
•4) after first visit, URS=2 and urination number per day >8 and/or urge incontinence
•5) agreed the study

•1) diagnosed UTI in U/A
•2) stress incontinence without symptoms of OAB
•3) suspicious neurologic bladder
•4) history of cystocele, hysterocele
•5) history of obstrcutive uropathy ; urolithiasis, tumor, etc
•6) history of bladder surgery
•7) history of urinary malignant tumor
•8) history of neuropsychiatric disease (schizophrenia, drug addiction, epilepsy, etc)
•9) The other condition, which makes the patient unsuitable for inclusion in the opinion of investigator
•(uncontrolled HTN, DM, thyroid disease, acute, chronic hepatitis/cirrhosis, severe hyperlipidemia, severe heart disease, Tbc, ather infectional disease)
•10) hypersensitivity, allergy og the study related drug
•11) OMD diagnose '????' ; dehydration oral cavitiy, redness of tongue, face, eyes, sweating at night, etc
•12) parcipication in other clinical trial within 3months
•13) use of drugs within 1months preceding bladder function
•(Tolterodine, Trospium, Solifenacin, Propantheline, Atropine, Hyoscyamine, Fesoterodine fumarate, Oxybutynin, Propiverine, Imipramine, Alfuzosin, Doxazocin, Prazosin,Terazosin, Tamsulosin, etc)
•14) unsuitable condition which intake herb medication because of systemic disease
•15) person who did not writing

发起方